Human &bgr;TrCP protein
    8.
    发明授权
    Human &bgr;TrCP protein 失效
    人βTrCP蛋白

    公开(公告)号:US06730486B1

    公开(公告)日:2004-05-04

    申请号:US09601168

    申请日:2000-07-28

    IPC分类号: C07K1400

    摘要: The present invention relates to the human &bgr;TrCP protein for the targeting of proteins towards proteasome degradation pathways, which is capable of interacting with the Vpu protein of HIV-1 virus, with the cell proteins I&kgr;B and &bgr;-catenin and with the cell protein Skp1p, to its peptide fragments and to the nucleic acid sequences coding for said protein and its fragments. It further relates to the use of the human &bgr;-TrCP protein or its peptide fragments for the screening of anti-HIV-1 antiviral agents, antitumoral agents and anti-inflammatory agents, to the antiviral agents, antitumoral agents and anti-inflammatory agents, and to the antibodies directed against said protein and its peptide fragments.

    摘要翻译: 本发明涉及用于将蛋白质靶向蛋白酶体降解途径的人βTrCP蛋白,其能够与HIV-1病毒的Vpu蛋白与细胞蛋白IkappaB和β-连环蛋白以及与细胞蛋白Skp1p相互作用, 涉及其肽片段和编码所述蛋白质及其片段的核酸序列。还涉及人β-TrCP蛋白或其肽片段用于筛选抗HIV-1抗病毒剂,抗肿瘤剂和 抗炎剂,抗病毒剂,抗肿瘤剂和抗炎剂,以及针对所述蛋白质及其肽片段的抗体。